Feasibility and clinical decision-making with 3D echocardiography in routine practice

Objective: To assess the feasibility and potential impact of routine three-dimensional (3D) echocardiographic assessment of left ventricular (LV) ejection fraction and volumes on clinical decision-making. Methods: Patients referred to three hospital-based echocardiography laboratories underwent 2D echocardiography (2DE) and 3D echocardiography (3DE). Feasibility was assessed in a group of 168 unselected patients and decision-making assessed within an expanded group of 220 patients. The time for acquisition and measurement was obtained. Feasibility was defined by ability to measure LV parameters. The potential of 3DE to alter clinical decisions based on 2DE was evaluated by the ability to identify four clinically relevant measurement thresholds: (1) LV end-systolic volume (LVESV) >50 ml/m2 (indication for surgery in regurgitant valve disease); (2) LVESV >30 ml/m2 (prognosis after infarction); (3) LV ejection fraction (LVEF) <35% (indication for implantable defibrillator); and (4) LVEF <40% (indication for heart failure treatment). Results: 3DE was technically feasible in 83% of unselected patients. The additional time for 3D acquisition and measurement was available in 184 patients and was 5.4 (SD 2.0) minutes. The use of 3DE changed categorisation in between 6–11% of patients. Within threshold categories, 3D reallocated 17.5% (11/63) of patients with LVEF <35%, 16.1% (13/81) for LVEF <40%, 12.4% (13/105) for LVESV >30 ml/m2 and 8.5% (5/59) for LVESV >50 ml/m2. Most of the impact of 3D was within 10 ml/m2 of selected volume thresholds (⩾75%) and 10% of EF thresholds (>80%). Conclusion: Measurement of LV volumes and EF by 3DE is clinically feasible and has the potential to significantly alter clinical decision-making.

[1]  Marcus Schreckenberg,et al.  High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[2]  M. G. St. John Sutton.  Predictors of long-term survival after valve replacement for chronic aortic regurgitation. , 2001, European heart journal.

[3]  B. Massie,et al.  Chronic aortic insufficiency: factors associated with progression to aortic valve replacement. , 1989, Annals of internal medicine.

[4]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[5]  Victor Mor-Avi,et al.  Improved semiautomated quantification of left ventricular volumes and ejection fraction using 3-dimensional echocardiography with a full matrix-array transducer: comparison with magnetic resonance imaging. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  J B Seward,et al.  Echocardiographic assessment of left ventricular remodeling: are left ventricular diameters suitable tools? , 1997, Journal of the American College of Cardiology.

[7]  Jonathan Chan,et al.  Accuracy and feasibility of online 3-dimensional echocardiography for measurement of left ventricular parameters. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  T. Marwick,et al.  Three-dimensional echocardiography: research toy or clinical tool? , 2000, Heart, lung & circulation.

[9]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[10]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[11]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[12]  M. Schwerzmann,et al.  Relation between Directly Detected Patent Foramen Ovale and Ischemic Brain Lesions in Sport Divers , 2001, Annals of Internal Medicine.

[13]  Jeroen J. Bax,et al.  Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy , 2005, Circulation.

[14]  M. Simoons,et al.  Real-time transthoracic three-dimensional echocardiographic assessment of left ventricular volume and ejection fraction in congenital heart disease. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  Victor Mor-Avi,et al.  Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data. , 2006, European heart journal.

[16]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[17]  Victor Mor-Avi,et al.  Quantitative Assessment of Left Ventricular Size and Function: Side-by-Side Comparison of Real-Time Three-Dimensional Echocardiography and Computed Tomography With Magnetic Resonance Reference , 2006, Circulation.

[18]  M. Sutton.  Predictors of long-term survival after valve replacement for chronic aortic regurgitation. , 2001 .

[19]  S. Yusuf,et al.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.

[20]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.

[21]  A. Gopal,et al.  Visual estimation of ejection fraction by two‐dimensional echocardiography: The learning curve , 1995, Clinical cardiology.

[22]  E. Braunwald,et al.  End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. , 1980, The American journal of medicine.

[23]  T. Marwick,et al.  Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. , 2004, Journal of the American College of Cardiology.

[24]  P. Wilmshurst,et al.  RELATION BETWEEN INTERATRIAL SHUNTS AND DECOMPRESSION SICKNESS IN DIVERS , 1989, The Lancet.

[25]  Jonathan Chan,et al.  What is the optimal clinical technique for measurement of left ventricular volume after myocardial infarction? A comparative study of 3-dimensional echocardiography, single photon emission computed tomography, and cardiac magnetic resonance imaging. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  Dan M Roden,et al.  [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. , 2006, Revista espanola de cardiologia.

[27]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[28]  D. Levy,et al.  Natural History of Asymptomatic Left Ventricular Systolic Dysfunction in the Community , 2003, Circulation.

[29]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[30]  Mark J Monaghan,et al.  Role of real time 3D echocardiography in evaluating the left ventricle , 2005, Heart.

[31]  K. Chan,et al.  Impact of three-dimensional echocardiography in valvular heart disease , 2005, Current opinion in cardiology.

[32]  M. Starling.  Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation. , 1995, Circulation.

[33]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  Salim Yusuf,et al.  The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. , 2002, Journal of the American College of Cardiology.